PharmaCyte Biotech (PMCB) Balance Sheet: Assets & Liabilities

PharmaCyte Biotech (PMCB) Balance Sheet

As of Apr 30, 2026 (end of fiscal 2026), PharmaCyte Biotech reported total assets of $46.75M and total liabilities of $11.77M. Shareholders' equity was $34.98M, down 32.6% from $51.89M a year earlier. Total debt stood at $0.00 against $37.08M in cash and short-term investments, a net cash position of $37.08M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

PharmaCyte Biotech Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for PharmaCyte Biotech, Inc. (PMCB) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Apr 2026	Apr 2025	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017
Current Assets
Cash and Cash Equivalents	18.60	15.17	50.18	68.04	85.40	2.20	0.89	0.52	1.06	3.46
Short-Term Investments	18.48	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	37.08	15.54	50.18	68.04	85.40	2.20	0.89	0.52	1.06	3.46
Accounts Receivable	0.24	3.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.10	0.22	0.26	0.11	0.09	0.07	0.14	0.14	0.22	0.07
Total Current Assets	37.42	22.38	50.44	68.15	85.49	2.28	1.04	0.65	1.28	3.54
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Investments	0.00	22.47	0.00	1.57	1.57	1.57	1.57	1.57	1.57	1.57
Intangible Assets	0.00	1.55	1.55	3.55	3.55	3.55	3.55	3.55	3.55	3.55
Other Non-Current Assets	0.01	0.01	0.01	0.01	0.01	3.56	0.01	0.01	0.01	0.01
Total Non-Current Assets	9.33	32.79	9.46	5.13	5.13	5.13	5.13	5.13	5.13	5.13
Total Assets	46.75	55.17	59.90	73.28	90.62	7.40	6.17	5.78	6.41	8.67
Current Liabilities
Accounts Payable	0.27	0.40	0.39	0.13	0.21	0.17	0.19	0.12	0.35	0.37
Short-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.00	0.00	0.00
Accrued Liabilities	0.56	2.49	0.40	0.40	0.50	0.55	-	-	-	-
Other Current Liabilities	0.56	2.52	6.30	0.40	0.50	0.55	0.82	0.62	0.29	0.21
Total Current Liabilities	0.83	2.91	7.42	0.59	0.70	0.72	1.03	0.74	0.64	0.58
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.05	0.00	0.00	0.00
Other Non-Current Liabilities	9.26	0.36	12.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	10.95	0.36	12.97	0.00	0.00	0.00	0.05	0.00	0.00	0.00
Total Liabilities	11.77	3.28	20.39	0.59	0.70	0.72	1.08	0.74	0.64	0.58
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.12	0.10	0.09
Retained Earnings	-104.39	-84.97	-115.63	-115.96	-111.65	-107.41	-103.86	-100.03	-95.96	-89.14
Accumulated Other Comprehensive Income	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.01	0.00	0.00
Treasury Stock	45.01	44.61	42.04	13.56	-	-	-	-	-	-
Additional Paid-in Capital	182.72	181.49	185.33	202.23	201.58	114.11	108.81	104.97	101.64	97.13
Minority Interest	1.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Shares Outstanding	10.74	6.80	8.04	16.79	20.72	-	-	-	-	-
Total Stockholders' Equity	34.98	51.89	39.51	72.69	89.92	6.68	5.09	5.04	5.77	8.09
Total Liabilities & Equity	46.75	55.17	59.90	73.28	90.62	7.40	6.17	5.78	6.41	8.67

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About PharmaCyte Biotech Balance Sheet

How much debt does PharmaCyte Biotech have?

PharmaCyte Biotech had total debt of $0.00 as of Apr 30, 2026, against $37.08M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $0.00 a year earlier.

What are PharmaCyte Biotech's total assets?

PharmaCyte Biotech reported total assets of $46.75M as of Apr 30, 2026, down 15.3% from $55.17M a year earlier. Total liabilities were $11.77M.

What is PharmaCyte Biotech's shareholders' equity?

PharmaCyte Biotech's shareholders' equity was $34.98M as of Apr 30, 2026, or about $3.26 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition